SOCM
KALA icon

SR One Capital Management’s KALA BIO KALA Stock Holding History

SR One Capital Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,979
Closed -$2.85M – 13
2025
Q2 		$2.85M Hold
11,979
– – 0.62% 12
2025
Q1 		$3.43M Hold
11,979
– – 0.88% 11
2024
Q4 		$4.16M Buy
11,979
+3,106
+35% +$979K 1.01% 11
2024
Q3 		$2.53M Hold
8,873
– – 0.51% 11
2024
Q2 		$3.15M Buy
+8,873
New +$2.93M 0.98% 9

Other funds holding KALA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SR One Capital Management's KALA Position: Q3 2025 in Review

SR One Capital Management sold out of KALA BIO (KALA) in Q3 2025, closing a stake of 11,979 shares — an estimated $2.85M sold.

SR One Capital Management first reported a position in KALA in Q2 2024 and held it in 5 quarters. The position peaked at $4.16M in Q4 2024. 22 funds tracked by Wall St. Rank hold KALA as of Q3 2025.

  • SR One Capital Management reported no remaining KALA BIO position as of Q3 2025 after selling out during the quarter.
  • SR One Capital Management sold 11,979 KALA BIO shares in Q3 2025, an estimated $2.85M.
  • SR One Capital Management first reported a position in KALA BIO in Q2 2024 and held it in 5 quarters.
  • SR One Capital Management's KALA BIO position peaked at $4.16M in Q4 2024.
  • 22 funds tracked by Wall St. Rank held KALA BIO as of Q3 2025.

Based on SR One Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.